Spectronaut® 19 offers significant improvements in identifications, candidate discovery, scalability for large-scale analysis, and support for novel workflows Novel TrueDiscovery® P2 Plasma Enrichment ...

Biognosys’ Spectronaut ®, the leading vendor-agnostic software for DIA proteomics, is now directly available from Thermo Fisher Scientific under a reselling agreement End users can get access to ...

SCHLIEREN, Switzerland--(BUSINESS WIRE)--Biognosys, a leader in next-generation proteomics solutions for life sciences research and development, announced today the launch of Spectronaut 15. The ...

ZURICH, Switzerland and CANCUN, Mexico, Dec. 05, 2022 (GLOBE NEWSWIRE) -- Biognosys, a leader in next-generation proteomics solutions for life science research and drug development, will launch ...

ZURICH and BOSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Biognosys, a global leader in mass spectrometry-based proteomics solutions, announces the launch of Spectronaut ® 20 and SpectroMine ™ 5 at the ASMS ...

Spectronaut® 18 makes DIA proteomics projects more efficient and scalable than ever for all mass spectrometry instrument types Novel research with TrueDiscovery™ and TrueTarget™ demonstrates the ...

Biognosys AG has announced the second release of its Spectronaut™ software for analysis of Hyper Reaction Monitoring (HRM) data. HRM is a targeted proteomics technology that enables reproducible and ...

Data-independent acquisition (DIA) has become the method of choice for large-scale discovery proteomics. Its application for single-cell analysis promises to be more sensitive, robust, and ...

Highlights include the launch of Spectronaut® 16, which has undergone one of its most transformative upgrades to date, and innovations to Biognosys’ proprietary TrueTarget™ and TrueDiscovery™ ...